Time to reperfusion with direct coronary angioplasty and thrombolytic therapy in acute myocardial infarction.

[1]  P. Kudenchuk,et al.  Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. , 1993, JAMA.

[2]  U. Tebbe,et al.  Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies. , 1993, Journal of the American College of Cardiology.

[3]  L. Becker,et al.  TIMI Perfusion Grade 3 but Not Grade 2 Results in Improved Outcome After Thrombolysis for Myocardial Infarction Ventriculographic, Enzymatic, Electrocardiographic Evidence From the TEAM‐3 Study , 1993, Circulation.

[4]  K. Bailey,et al.  Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. , 1993, The New England journal of medicine.

[5]  R. Magorien,et al.  Myocardial infarct artery patency and reocclusion rates after treatment with duteplase at the dose used in the International Study of Infarct Survival-3. Burroughs Wellcome Study Group. , 1993, The American journal of cardiology.

[6]  G. A. Murphy,et al.  Randomized angiographic trial of recombinant tissue-type plasminogen activator (alteplase) in myocardial infarction. RAAMI Study Investigators. , 1992, Journal of the American College of Cardiology.

[7]  U. Tebbe,et al.  Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS) , 1992, Journal of the American College of Cardiology.

[8]  David Hunt,et al.  ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION , 1992 .

[9]  K. Fox,et al.  Effect of "fast track" admission for acute myocardial infarction on delay to thrombolysis. , 1992, BMJ.

[10]  J. Anderson,et al.  Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. Second Multicenter Thrombolysis Trial of Eminase in Acute Myocardial Infarction. , 1992, Journal of the American College of Cardiology.

[11]  J. Ornato,et al.  Prospective multicenter assessment of critical factors delaying hospital thrombolytic therapy , 1991 .

[12]  B. Brodie,et al.  Outcomes of direct coronary angioplasty for acute myocardial infarction in candidates and non-candidates for thrombolytic therapy. , 1991, The American journal of cardiology.

[13]  B. Rutherford,et al.  Results of primary angioplasty for acute myocardial infarction in patients with multivessel coronary artery disease. , 1990, Journal of the American College of Cardiology.

[14]  D. Morris,et al.  Improved infarct-related arterial patency after high dose, weight-adjusted, rapid infusion of tissue-type plasminogen activator in myocardial infarction: results of a multicenter randomized trial of two dosage regimens. , 1990, Journal of the American College of Cardiology.

[15]  E. Ruiz,et al.  An analysis of time delays preceding thrombolysis for acute myocardial infarction. , 1989, JAMA.

[16]  J. O’Keefe,et al.  Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction. , 1989, The American journal of cardiology.

[17]  U. Tebbe,et al.  Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator. , 1989, Journal of the American College of Cardiology.

[18]  R. Califf,et al.  From myocardial salvage to patient salvage in acute myocardial infarction: the role of reperfusion therapy. , 1989, Journal of the American College of Cardiology.

[19]  E. Topol,et al.  Coronary angioplasty as primary therapy for acute myocardial infarction 6 to 48 hours after symptom onset: report of an initial experience. , 1989, Journal of the American College of Cardiology.

[20]  A. M. Skene,et al.  TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION Anglo-Scandinavian Study of Early Thrombolysis (ASSET) , 1988, The Lancet.

[21]  H. Lambertz,et al.  THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY , 1988, The Lancet.

[22]  K. Lee,et al.  A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. , 1987, The New England journal of medicine.

[23]  S. Forman,et al.  Thrombolysis in myocardial infarction (TIMI): comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activator. , 1987, Journal of the American College of Cardiology.

[24]  D. Rothbaum,et al.  Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: a 3 year experience. , 1987, Journal of the American College of Cardiology.

[25]  R Roberts,et al.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. , 1987, Circulation.

[26]  E. Topol,et al.  A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarction. , 1987, Journal of the American College of Cardiology.

[27]  B. Pitt,et al.  A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. , 1986, The New England journal of medicine.

[28]  B. Rutherford,et al.  Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. , 1983, American heart journal.

[29]  T. Waterston.  FLUIDS FOR DIARRHŒA IN YOUNG CHILDREN , 1977, The Lancet.

[30]  Williams Ea.  Letter: Caesarean section. , 1976 .

[31]  H. Huisjes,et al.  OMPHALOCELE AND RAISED ALPHA-FETOPROTEIN IN AMNIOTIC FLUID , 1975, The Lancet.

[32]  E. Veys,et al.  HL-A AND INFECTIVE SACROILEITIS , 1974 .